Roivant Sciences Ltd.

NASDAQ: ROIV · Real-Time Price · USD
11.80
0.05 (0.43%)
At close: Aug 15, 2025, 12:16 PM

Roivant Sciences Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Revenue
29.05M 124.8M 61.28M 55.29M
Cost of Revenue
911K 27.96M 13.13M 8.97M
Gross Profit
28.14M 96.83M 48.15M 46.32M
Operating Income
-1B 4.24B -1.18B -1.35B
Interest Income
258.38M 146.43M 32.18M 369K
Pretax Income
-681.59M 4.25B -1.22B -923.75M
Net Income
-171.98M 4.35B -1.01B -845.26M
Selling & General & Admin
591.41M 675.04M 600.51M 775.03M
Research & Development
550.41M 501.74M 525.22M 483.04M
Other Expenses
-110.39M -5.32B 97.75M 139.89M
Operating Expenses
1.03B -4.13B 1.22B 1.4B
Interest Expense
n/a 34.78M 27.97M 7.04M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
1.03B -4.12B 1.24B 1.41B
Income Tax Expense
48.17M 22.22M 5.19M 369K
Shares Outstanding (Basic)
725.4M 783.25M 712.79M 669.75M
Shares Outstanding (Diluted)
725.4M 831.05M 712.79M 669.75M
EPS (Basic)
-0.24 5.55 -1.42 -1.26
EPS (Diluted)
-0.24 5.23 -1.42 -1.26
EBITDA
-1.1B 4.31B -1.18B -916.71M
EBIT
-1.11B 4.29B -1.2B -916.71M
Depreciation & Amortization
7.33M 22.04M 18.86M 5.93M